Executive Summary
The February 5, 2026 overnight SEC filings batch (125 total) is dominated by ~85 Item 2.02 earnings releases across sectors like healthcare (Bristol Myers Squibb, Haemonetics), finance/asset management (TPG, KKR, Ares, Blue Owl), consumer (Tapestry, Hershey, Energizer), industrials/energy (Cummins, Patterson UTI, Peabody), and tech (Alphabet 10-K), signaling a major premarket earnings catalyst cluster with high materiality (avg 6.8/10). Sentiment remains overwhelmingly neutral (123/125 filings) due to no disclosed period-over-period metrics, guidance, insider trades, or capital allocation details in summaries, implying stable operations absent major surprises in exhibits; investors must review Item 9.01 attachments for YoY/QoQ trends. Bearish outliers include two material agreement terminations (Brand Engagement Network, UPEXI), while M&A activity (ETHZilla close, STRATUS assets, Broadwind agreement) adds neutral-to-bullish deal flow. No portfolio-level trends like margin compression or revenue growth visible (0/125 quantified), but high filing volume suggests broad market rotation potential based on relative guidance. Medium-risk events cluster around equity issuances (Planet Labs, P10 dilution risk) and leadership changes (10+ Item 5.02). Overall low risk (avg low), focus on premarket reactions and catalyst calendar from earnings calls.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from February 03, 2026.
Investment Signals(12)
- Brand Engagement Network Inc↓(BEARISH)▲
Termination of material definitive agreement (Item 1.02), bearish sentiment, medium risk, potential revenue hit undisclosed
- UPEXI, INC↓(BEARISH)▲
Termination of material definitive agreement (Item 1.02), bearish sentiment, medium risk, strategic setback with unknown financial impact
- Planet Labs PBC↓(BEARISH)▲
Unregistered equity sales (Item 3.02) + material modifications to security holders' rights (Item 3.03), medium risk dilution signal
- Edible Garden AG Inc↓(BEARISH)▲
Unregistered sales of equity securities (Item 3.02), medium risk, potential shareholder dilution without quantified proceeds
- KKR & Co. Inc↓(BEARISH)▲
Unregistered equity sales (Item 3.02), neutral but dilution concern in asset mgmt sector
- P10, Inc↓(NEUTRAL)▲
Entry into material definitive agreement (Item 1.01) + unregistered equity sales, potential growth but dilution offset, materiality 8/10
- ETHZilla Corp↓(BULLISH)▲
Completion of acquisition/disposition (Item 2.01) + material agreement (Item 1.01), multi-event close signals execution, medium risk
- STRATUS PROPERTIES INC↓(BULLISH)▲
Entry into material agreement (Item 1.01) + asset acquisition/disposition completion (Item 2.01), deal momentum, materiality 8/10
- CORPAY, INC↓(BULLISH)▲
Completion of acquisition/disposition (Item 2.01, 8-K/A), post-close synergies potential
- Broadwind, INC↓(BULLISH)▲
Material definitive agreement (Item 1.01) + financial obligation (Item 2.03) + earnings, strategic financing for growth, materiality 8/10
- Jerash Holdings (US), Inc↓(BULLISH)▲
Entry into material definitive agreement (Item 1.01), medium risk but expansion signal
- Alphabet Inc↓(BULLISH)▲
Annual 10-K filing, medium risk, materiality 8/10, review for long-term trends absent quarterly volatility
Risk Flags(10)
- Brand Engagement Network/Termination↓[HIGH RISK]▼
Bearish sentiment from Item 1.02 termination, medium risk, unknown financial/operational impact requires follow-up
- UPEXI/Termination↓[HIGH RISK]▼
Bearish on material agreement end (Item 1.02), medium risk, potential cash flow disruption
- Planet Labs/Equity Issuance↓[MEDIUM RISK]▼
Item 3.02 unregistered sales + Item 3.03 rights modifications, medium risk dilution across multiple holders
- ETHZilla Corp/M&A + Leadership↓[MEDIUM RISK]▼
Acquisition close (Item 2.01) + officer changes (Item 5.02), medium risk integration/turnover issues
- Broadwind/Financial Obligation↓[MEDIUM RISK]▼
Item 2.03 creation of direct obligation + debt-like arrangement amid earnings, medium risk leverage spike
- urban-gro/Governance Changes↓[MEDIUM RISK]▼
Item 3.03 rights mods + Item 5.03 bylaws amendments, medium risk shareholder value erosion
- Fly-E Group/Officer Departure↓[MEDIUM RISK]▼
Item 5.02 unspecified leadership change, medium risk stability concerns
- Profusa, Inc/Governance↓[MEDIUM RISK]▼
Item 3.03 rights changes + Item 5.03 amendments + Item 8.01 events, medium risk structural shifts
- LB Pharmaceuticals/Equity + Debt↓[MEDIUM RISK]▼
Item 3.02 sales + Item 1.01 agreement, medium risk dilution + unknown obligations
- MKS INC/Financial Obligation↓[MEDIUM RISK]▼
Item 2.03 off-balance sheet + Item 1.01 agreement, medium risk hidden leverage
Opportunities(8)
- ETHZilla Corp/Acquisition Close↓(OPPORTUNITY)◆
Item 2.01 completion offers post-merger alpha if synergies materialize, review exhibits for valuation/terms
- STRATUS PROPERTIES/Asset Deal↓(OPPORTUNITY)◆
Dual Item 1.01/2.01 signals property sector M&A momentum, materiality 8/10
- CORPAY, INC/Asset Acquisition↓(OPPORTUNITY)◆
8-K/A on Item 2.01 completion, potential undervalued add-on, track integration
- Broadwind/Strategic Agreement↓(OPPORTUNITY)◆
Item 1.01 entry + earnings combo positions for industrial growth, despite 2.03 obligation
- Alphabet Inc/10-K Review↓(OPPORTUNITY)◆
Annual filing materiality 8/10, opportunity for deep dive into tech trends absent short-term noise
- P10, Inc/Material Agreement↓(OPPORTUNITY)◆
Item 1.01 deal + Reg FD (7.01), alpha in asset mgmt consolidation
- Jerash Holdings/Definitive Agreement↓(OPPORTUNITY)◆
Item 1.01 entry, potential supply chain/expansion play in apparel
- High-Materiality Earnings Cluster (Tapestry, Bristol Myers, Cummins)(OPPORTUNITY)◆
7-8/10 materiality Item 2.02 filings, relative outperformance if exhibits show YoY beats
Sector Themes(6)
- Earnings Wave Across Sectors◆
~85/125 filings Item 2.02 (healthcare 12+, finance 8+, consumer 10+, industrials/energy 15+), premarket volatility catalyst, no disclosed QoQ trends but high materiality avg 7/10 implies guidance focus
- Asset Management Neutral Reporting◆
TPG, KKR, Ares, AllianceBernstein, Blue Owl all Item 2.02 neutral, watch fee/asset trends in exhibits for AUM growth conviction
- Microcap Agreement Disruptions◆
2/125 bearish terminations (Brand Engagement, UPEXI) in small caps, pattern of deal breaks signals caution in speculative names
- M&A/Dealmaking Uptick◆
7+ filings with Item 1.01/2.01 (ETHZilla, STRATUS, Broadwind, P10), neutral sentiment but medium risk, implies resilient transaction flow
- Dilution via Equity Sales◆
6+ Item 3.02 (Planet Labs, KKR, Edible Garden, P10), medium risk pattern in growth/specialty firms, compare to cash needs in earnings
- Leadership Flux in Small/Midcaps◆
12+ Item 5.02 (Fly-E, Sotera, Imunon, Sonim), neutral but medium risk, monitor for conviction via future insider activity
Watch List(8)
- All Item 2.02 Filers (Cummins, TPG, Bristol Myers, Tapestry, etc.)/Earnings Exhibits(URGENT)👁
Review Item 9.01 for undisclosed YoY/QoQ metrics, guidance, ratios; premarket open Feb 5 2026
Follow-up 8-K/S-1 for financial effects of Item 1.02, potential guidance cut [NEXT 1-2 WEEKS]
- UPEXI/Termination Fallout↓(IMMEDIATE)👁
Monitor Q results post-agreement end for revenue gap, medium risk
Integration updates, leadership stability (Item 5.02), scheduled events in exhibits [Q1 2026]
- Planet Labs/Equity Dilution↓(WEEKLY)👁
Track shareholder impacts from Item 3.02/3.03, compare holdings post-transaction
- Alphabet Inc/10-K Deep Dive↓(THIS WEEK)👁
Extract operational metrics, forward-looking from annual report, insider patterns
- Officer Change Cohorts (Fly-E, STAAR Surgical, 3M)/Stability👁
Watch Form 4 insider trades for conviction post-Item 5.02 [30 DAYS]
- M&A Actives (STRATUS, Broadwind)/Deal Terms👁
Upcoming calls/AGMs for synergies, capital allocation details [FEB-MAR 2026]
Filing Analyses(125)
05-02-2026
Cummins Inc filed an 8-K on February 5, 2026 (AccNo: 0000026172-26-000004), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no quantified positive or negative performance indicators available.
05-02-2026
LM Funding America, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.
05-02-2026
TPG Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001880661-26-000003, size 11 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified financial impacts.
- ·AccNo: 0001880661-26-000003
05-02-2026
Haemonetics Corp filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits.
05-02-2026
Bristol Myers Squibb Co filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific quantitative metrics such as revenue, earnings, or guidance are mentioned in the provided information. No positive or negative performance indicators, comparisons, or other details are available.
05-02-2026
Tapestry, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001140361-26-003783), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard earnings-related disclosure without detailed performance data available.
- ·File size: 1 MB
- ·Sector: not specified
05-02-2026
Energizer Holdings, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results announcement, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive, negative, or flat performance indicators are provided in the filing details.
05-02-2026
Insight Enterprises Inc filed an 8-K on February 5, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative impacts mentioned.
05-02-2026
Suburban Propane Partners LP filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
05-02-2026
Daily Journal Corp filed a Form 8-K on February 5, 2026 (AccNo: 0001437749-26-003058, Size: 171 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This appears to be a multi-item, primarily voluntary disclosure as Item 8.01 covers events not specified under other mandatory items.
05-02-2026
05-02-2026
REGIS CORP filed a Form 8-K on February 5, 2026, specifically under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing information. Sector details are not specified.
05-02-2026
Cipher Mining Inc. filed a Form 8-K on 2026-02-05 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), with file size 253 KB and AccNo 0000950103-26-001659. No specific details on the nature of the other events, financial statements, exhibits, quantitative metrics, positive or negative changes, or performance comparisons are disclosed. Critical event details are missing, preventing assessment of materiality or impact.
- ·File size: 253 KB
- ·AccNo: 0000950103-26-001659
05-02-2026
Brand Engagement Network Inc. filed an 8-K on 2026-02-05 disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement parties, value, financial impact, or strategic context were provided.
05-02-2026
KKR & Co. Inc. filed a Form 8-K on February 05, 2026, disclosing unregistered sales of equity securities under Item 3.02 and Regulation FD disclosure under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on transaction size, shares, financial metrics, or impacts were provided in the filing summary.
05-02-2026
Prestige Consumer Healthcare Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.
05-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 05, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing information. The filing accession number is 0001062993-26-000623 with a file size of 855 KB.
- ·Accession Number: 0001062993-26-000623
- ·File Size: 855 KB
05-02-2026
Ares Management Corp filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing information. This multi-item filing appears informational with no detailed positive or negative performance indicators available.
05-02-2026
Deluxe Corp filed an 8-K on February 5, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the filing summary. No positive or negative performance indicators, period-over-period comparisons, or material changes are disclosed.
05-02-2026
DORIAN LPG LTD. filed a Form 8-K on February 5, 2026 (AccNo: 0001596993-26-000010), under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item filing related to financial results announcement. No specific revenue, earnings, balance sheet details, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.
05-02-2026
EXOZYMES INC. filed a Form 8-K on February 05, 2026 (AccNo: 0001493152-26-005176, Size: 241 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, any financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing information. This is a multi-item filing with no quantitative data or directional implications provided.
05-02-2026
SPACSphere Acquisition Corp. filed an 8-K on 2026-02-05 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year, while Item 9.01 includes financial statements and exhibits. No quantitative metrics, deal terms, personnel names, amendment details, or merger/acquisition specifics were explicitly stated.
05-02-2026
The company filed an 8-K on February 5, 2026 (AccNo: 0000072903-26-000006), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a financial results announcement, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period comparisons, or operational highlights are mentioned.
05-02-2026
Planet Labs PBC filed a Form 8-K on February 5, 2026, disclosing events under Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction values, share counts, financial metrics, or period-over-period comparisons provided. Critical details such as dollar amounts, impacts, or strategic context are NOT_DISCLOSED.
05-02-2026
The company filed an 8-K on February 5, 2026 (AccNo: 0001140361-26-003755), disclosing Item 3.02: Unregistered Sales of Equity Securities. No quantitative details such as transaction value, share count, recipients, exemptions relied upon, or use of proceeds were mentioned. This appears to be a single-item mandatory filing with no specified financial metrics or comparisons.
05-02-2026
The company filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as the affected position (e.g., CEO, CFO), individual names, nature of change (appointment or resignation), reasons, or timing are explicitly stated in the provided filing information. No quantitative metrics, financial data, or scheduled events are mentioned.
05-02-2026
Myseum, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001213900-26-012400, Size: 263 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative data or directional impacts mentioned.
05-02-2026
UPEXI, INC. filed an 8-K on 2026-02-05 disclosing the termination of a material definitive agreement under Item 1.02. The filing also reports financial statements and exhibits under Item 9.01. No details on the agreement, transaction value, financial impact, or other metrics were provided.
05-02-2026
Patterson UTI Energy Inc filed an 8-K on 2026-02-05 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory filing typical for quarterly earnings releases.
05-02-2026
Fly-E Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
05-02-2026
Cigna Group filed an 8-K on 2026-02-05 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or period-over-period metrics were provided in the filing summary. This appears to be a standard earnings-related disclosure without detailed quantitative impacts.
- ·AccNo: 0001140361-26-003768
- ·Filing size: 769 KB
- ·Event Type: Financial Results
- ·Sector: NOT_DISCLOSED
05-02-2026
News Corp filed a Form 8-K on February 05, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or impacts are provided in the filing summary. This appears to be a multi-item, likely voluntary disclosure with attached exhibits.
05-02-2026
Trailblazer Merger Corp I filed an 8-K on 2026-02-05 under Item 8.01 Other Events related to a merger/acquisition event. No quantitative metrics, deal structure details, financial terms, parties involved, strategic rationale, or timelines were explicitly stated in the filing summary. Sector is not specified, and all key transaction information remains NOT_DISCLOSED.
05-02-2026
The company filed an 8-K on February 5, 2026, reporting unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. This is a multi-item filing with no specific details provided on transaction size, shares issued, pricing, buyers, or financial impact. No quantitative metrics, guidance changes, or scheduled events were disclosed.
05-02-2026
NORTHERN MINERALS & EXPLORATION LTD. filed an 8-K on February 05, 2026 (AccNo: 0001437749-26-003029, Size: 158 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements/exhibits are disclosed. This multi-item filing appears informational without quantified positive or negative metrics.
- ·File Size: 158 KB
- ·Accession Number: 0001437749-26-003029
05-02-2026
AllianceBernstein Holding L.P. filed an 8-K on February 5, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing information.
05-02-2026
The company filed an 8-K on February 05, 2026 (AccNo: 0001109448-26-000011, Size: 824 KB) reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results event announcement. No specific revenue, earnings, guidance, comparisons, or other quantitative financial metrics are disclosed in the provided filing information.
05-02-2026
CMS Energy Corp filed a Form 8-K on 2026-02-05 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period changes, or other financial details are available.
05-02-2026
National Bank Holdings Corp filed an 8-K on February 05, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
05-02-2026
Global Net Lease, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001104659-26-010582), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information via attached exhibits, likely a press release or presentation, but specific content, financial metrics, transactions, or events are NOT_DISCLOSED. No positive or negative metrics, guidance, or impacts are detailed.
05-02-2026
Cardinal Health Inc filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the filing description. No positive or negative performance indicators, guidance changes, or period-over-period comparisons are mentioned.
05-02-2026
XPO, Inc. filed an 8-K on February 05, 2026 (AccNo: 0001104659-26-010608) under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results with no specific revenue, earnings, or other metrics detailed in the provided filing information. No positive or negative performance indicators, guidance, or comparisons are disclosed.
05-02-2026
OneMain Holdings, Inc. filed a Form 8-K on February 5, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item informational filing typical for quarterly earnings releases.
05-02-2026
Snap-on Inc filed a Form 8-K on 2026-02-05 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided filing details. No positive or negative financial changes can be assessed due to lack of extracted data.
05-02-2026
Hershey Co filed an 8-K on February 5, 2026 (AccNo: 0001628280-26-005604), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings announcement filing with no detailed performance data available.
05-02-2026
Omnicell, Inc. filed an 8-K on February 5, 2026 (AccNo: 0000926326-26-000003), disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item voluntary earnings-related disclosure with no directional financial data available.
05-02-2026
XPO, Inc. filed an 8-K on February 5, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosure, financial metrics, transactions, or events are provided in the filing summary. This appears to be an informational filing with attached exhibits, but content is not disclosed.
05-02-2026
Thermon Group Holdings, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001489096-26-000020), reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.
05-02-2026
ITT Inc. filed a Form 8-K on February 5, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits, announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no detailed performance data available.
05-02-2026
Advanced Drainage Systems, Inc. filed an 8-K on February 05, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing likely related to financial results announcement.
- ·Filing Accession Number: 0001604028-26-000004
- ·Filing Size: 2 MB
05-02-2026
Nathan's Famous, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001437749-26-003080), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be an informational earnings-related disclosure without detailed performance data.
- ·Event Type: Financial Results
- ·Source: us_sec
- ·Size: 491 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
Liquidity Services Inc filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-038469), reporting under Item 2.02 Results of Operations and Financial Condition, with exhibits under Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, revenue, earnings, guidance, or balance sheet details were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance data.
05-02-2026
Orion Energy Systems, Inc. filed a Form 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.
05-02-2026
Ocular Therapeutix, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001104659-26-010633), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were explicitly stated in the provided filing details. This is a standard voluntary earnings-related disclosure without detailed performance metrics.
05-02-2026
Huntington Ingalls Industries, Inc. filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No quantitative financial metrics, revenue figures, earnings, guidance, period-over-period comparisons, or other specific data were explicitly stated in the provided filing description. This appears to be a standard earnings-related disclosure with no directional performance indicators available.
05-02-2026
NETSCOUT SYSTEMS INC filed a Form 8-K on February 5, 2026 (AccNo: 0001078075-26-000009), reporting results of operations and financial condition under Item 2.02 and providing financial statements and exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, guidance, or other performance details are disclosed in the provided filing information. This is a standard mandatory disclosure for financial results with no indicated positive or negative variances.
05-02-2026
Embecta Corp. filed a Form 8-K on February 5, 2026 (AccNo: 0001872789-26-000005), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a standard financial results disclosure with attached exhibits, but detailed performance data is NOT_DISCLOSED.
05-02-2026
Green Plains Inc. filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no directional financial performance indicators available.
05-02-2026
Carrier Global Corp filed an 8-K on February 5, 2026 (AccNo: 0001783180-26-000005) under Item 2.02 disclosing results of operations and financial condition. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed financial data available.
05-02-2026
KKR & Co. Inc. filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were mentioned in the provided filing details.
05-02-2026
Blue Owl Capital Inc. filed an 8-K on February 5, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. No positive, negative, or flat performance indicators are available for balanced analysis.
05-02-2026
SelectQuote, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. Detailed financial metrics and impacts remain NOT_DISCLOSED.
05-02-2026
Spectrum Brands Holdings, Inc. filed a Form 8-K on February 05, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.
05-02-2026
Asbury Automotive Group Inc filed a Form 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item filing for financial results announcement. No specific revenue, earnings, guidance, or period-over-period metrics were disclosed in the provided filing information.
05-02-2026
IQVIA Holdings Inc. filed an 8-K on February 5, 2026, under Item 2.02 to disclose results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed.
05-02-2026
Broadwind, Inc. filed a Form 8-K on 2026-02-05 reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons provided in the available information. Critical quantitative and qualitative details are NOT_DISCLOSED, limiting assessment of impacts.
05-02-2026
Malibu Boats, Inc. filed a Form 8-K on February 5, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing information. This represents a standard earnings-related disclosure with no directional financial metrics available.
05-02-2026
AvalonBay Communities Inc filed an 8-K on February 5, 2026 (AccNo: 0000915912-26-000002, Size: 4 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure for financial results.
- ·Filing Accession Number: 0000915912-26-000002
05-02-2026
Peloton Interactive, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons for the change, timing, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.
05-02-2026
Rockwell Automation, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional details available.
05-02-2026
Tradeweb Markets Inc. filed a Form 8-K on 2026-02-05 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing appears to accompany earnings release materials, but lacks quantified performance data.
05-02-2026
urban-gro, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the modifications, amendments, or disclosures provided in the available information. No quantitative metrics, financial impacts, or directional performance indicators are mentioned.
05-02-2026
Regal Rexnord Corp filed an 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing summary provided. This is a standard earnings-related disclosure with no detailed performance data available.
- ·Filing Accession Number: 0000082811-26-000041
- ·File Size: 965 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
MAXIMUS, INC. filed a Form 8-K on February 05, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are mentioned in the filing summary provided. This represents a standard earnings-related disclosure without detailed performance data.
05-02-2026
MasterCraft Boat Holdings, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001193125-26-038499, Size: 16 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing appears related to financial results but lacks quantitative data for performance analysis.
05-02-2026
WEC Energy Group, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary. This is a standard multi-item disclosure for financial results with no directional performance indicators provided.
05-02-2026
Ingles Markets Inc filed a Form 8-K on February 05, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but detailed financial data is NOT_DISCLOSED.
05-02-2026
MACOM Technology Solutions Holdings, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001493594-26-000016), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed results available.
- ·Filing size: 496 KB
- ·Source: us_sec
05-02-2026
Madison Square Garden Sports Corp. filed a Form 8-K on 2026-02-05 under Item 2.02 announcing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.
- ·AccNo: 0001628280-26-005609
- ·Filing size: 401 KB
- ·Sector: not specified
05-02-2026
P10, Inc. filed a Form 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction terms, values, parties, or financial impacts disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
05-02-2026
Edible Garden AG Inc filed an 8-K on February 5, 2026, reporting under Item 3.02 regarding unregistered sales of equity securities. No specific details on transaction size, share count, dollar value, recipients, or strategic context were disclosed. This is a single-item mandatory disclosure with no financial metrics or comparisons provided.
05-02-2026
Peabody Energy Corp filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This multi-item filing pertains to financial results with no mentioned positive or negative performance indicators.
05-02-2026
ConocoPhillips filed an 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are provided in the filing description. This is a standard earnings-related disclosure with file size of 2 MB and AccNo 0001163165-26-000005.
05-02-2026
Sotera Health Co filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative data are disclosed. Sector information is NOT_DISCLOSED.
05-02-2026
Stellus Capital Investment Corp filed an 8-K on February 5, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. No financial metrics, positive or negative changes, or period-over-period comparisons are mentioned.
05-02-2026
MARINE PRODUCTS CORP filed an 8-K on February 05, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific financial metrics, performance comparisons, or transaction details are NOT_DISCLOSED. No positive or negative metrics, guidance, or impacts are provided in the filing description.
05-02-2026
Telomir Pharmaceuticals, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001493152-26-005199, Size: 208 KB), reporting under Item 8.01 Other Events. No specific details on the nature of the events, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This is a voluntary, single-item disclosure with no quantitative data or period-over-period comparisons mentioned.
05-02-2026
The company filed an 8-K on February 5, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided or disclosed in the filing summary.
05-02-2026
Intercontinental Exchange, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001104659-26-010646), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary. No positive or negative financial changes are disclosed.
05-02-2026
Linde PLC filed an 8-K on February 5, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified impacts available.
05-02-2026
Griffon Corp filed an 8-K on February 5, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed.
05-02-2026
Profound Medical Corp. filed a Form 8-K on February 5, 2026 (AccNo: 0001171843-26-000643, size 226 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on voluntary disclosure of potentially material non-public information with attached exhibits. No specific financial metrics, transactions, quantitative data, positive or negative changes, or operational details are disclosed in the provided filing information.
05-02-2026
Jerash Holdings (US), Inc. filed a Form 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
05-02-2026
Estee Lauder Companies Inc filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed financial data available.
05-02-2026
SIRIUS XM HOLDINGS INC. filed an 8-K on February 05, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This is a multi-item informational filing related to financial results.
05-02-2026
Imunon, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, timing, or any quantitative data are disclosed. Sector is not specified.
05-02-2026
Patrick Industries Inc filed an 8-K on 2026-02-05 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.
05-02-2026
STAAR Surgical Co filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.
05-02-2026
BorgWarner Inc. filed an 8-K on February 5, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing includes voluntary disclosure of potentially material nonpublic information with attached exhibits, but no specific details, metrics, transactions, or events are provided in the filing metadata. No quantitative financial data or period-over-period comparisons disclosed.
05-02-2026
Agassi Sports Entertainment Corp. filed an 8-K on February 5, 2026, disclosing unregistered sales of equity securities under Item 3.02. No quantitative details such as transaction value, share count, or terms were provided in the filing summary. This is a mandatory disclosure for such events, but lacks specifics on scale or impact.
05-02-2026
MDU Resources Group Inc filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This is a multi-item filing related to financial results.
05-02-2026
Artelo Biosciences, Inc. filed an 8-K on February 5, 2026, reporting solely under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing metadata. Sector information is not specified.
- ·Accession Number: 0001640334-26-000221
- ·File Size: 145 KB
05-02-2026
Sonim Technologies Inc filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, appointment or resignation status, reasons for change, timing, or any compensatory terms are NOT_DISCLOSED. No quantitative metrics, financial data, or performance comparisons are provided in the filing summary.
05-02-2026
Profusa, Inc. filed an 8-K on 2026-02-05 reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the nature of modifications, amendments, events, or exhibits provided. No quantitative data, financial impacts, or directional biases are disclosed.
05-02-2026
NovoCure Ltd filed a Form 8-K on February 5, 2026 (AccNo: 0001645113-26-000007, Size: 145 KB) under Item 7.01 for Regulation FD Disclosure. This is a single-item filing with no additional quantitative financial metrics, transactions, or performance data disclosed. No positive, negative, or flat metrics are mentioned.
05-02-2026
ETHZilla Corp filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), indicating a merger/acquisition event has closed. The filing also addresses departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, parties involved, or performance impacts—positive or negative—are disclosed.
05-02-2026
AIM ImmunoTech Inc. filed a Form 8-K on February 05, 2026, disclosing under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, financial metrics, or transactions are provided in the filing summary. The filing size is 9 MB, suggesting possible attachments such as press releases or presentations.
05-02-2026
LB Pharmaceuticals Inc filed a Form 8-K on February 5, 2026, disclosing multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative financial details, transaction sizes, or performance metrics were provided in the filing summary. This multi-item filing signals potentially significant strategic developments but lacks specifics on impacts.
05-02-2026
ScanSource, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive, negative, or flat performance indicators are mentioned.
05-02-2026
MKS INC filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific details on the nature of the agreement, transaction size, financial terms, or impacts are provided in the filing summary. This is a multi-item filing with no quantified positive or negative metrics disclosed.
05-02-2026
LiveOne, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative financial data were disclosed in the provided filing details. This is a multi-item informational filing typical for earnings releases.
05-02-2026
Amphenol Corp /DE/ filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
05-02-2026
3M CO filed an 8-K on February 05, 2026 (AccNo: 0000066740-26-000037) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative implications can be assessed due to lack of details.
05-02-2026
UGI Corp (/PA/) filed a Form 8-K on February 05, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing details. This represents a standard voluntary earnings-related multi-item disclosure with no quantified positive or negative metrics available.
05-02-2026
Ralph Lauren Corp filed a Form 8-K on 2026-02-05 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No period-over-period comparisons, positive or negative changes, or detailed financial impacts are provided in the available information.
05-02-2026
Central Bancompany, Inc. filed an 8-K on 2026-02-05 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for changes, timing, or any quantitative financial metrics are disclosed. This is an informational filing with no period-over-period comparisons or directional performance indicators provided.
05-02-2026
Transcode Therapeutics, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure likely including a press release or update as an exhibit, with no specific financial metrics, transaction details, or quantitative data disclosed in the filing summary. No positive or negative performance metrics were mentioned.
05-02-2026
Microbot Medical Inc. filed an 8-K on February 5, 2026, under Item 7.01 for Regulation FD Disclosure, indicating voluntary release of material nonpublic information, and Item 9.01 for Financial Statements and Exhibits. No financial metrics, transaction details, period-over-period comparisons, or quantitative data are disclosed in the filing summary. This is a multi-item informational filing with no specified positive or negative impacts.
05-02-2026
InterDigital, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided information. All quantitative financial data is NOT_DISCLOSED.
05-02-2026
Ladder Capital Corp filed an 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided filing information. This is an informational earnings-related disclosure without quantified performance data.
05-02-2026
Post Holdings, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, individual involved, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
05-02-2026
CORPAY, INC. filed an 8-K on 2026-02-05 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific details on deal structure, parties, valuation, or financial impact are disclosed.
05-02-2026
STRATUS PROPERTIES INC filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 8.01 covers other events, and Item 9.01 includes financial statements and exhibits. No specific transaction details, parties, valuations, or financial metrics are disclosed.
05-02-2026
AGCO Corp /DE filed an 8-K on February 5, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative financial metrics available for analysis.
05-02-2026
Acadian Asset Management Inc. filed a Form 8-K on February 05, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics were provided in the filing description. No positive or negative performance indicators, guidance, or strategic details were mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 125 filings
🇺🇸 More from United States
View all →March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings